NCCN

Guideline Updates

NCCN B-Cell Lymphomas Guideline Features Therapy Updates in Follicular Lymphoma, DLBCL

07/13/2020

The National Comprehensive Cancer Network (NCCN) released an update to its guideline for B-cell lymphomas. In the section for follicular lymphoma with histologic transformation to diffuse large B-cell lymphoma...

The...

07/13/2020

Journal of Clinical Pathways

Guideline Updates

NCCN Updates Clinical Practice Guideline for Thyroid Carcinomas

06/22/2020

The National Comprehensive Cancer Network (NCCN) recently released an updated version of its clinical practice guideline for thyroid carcinomas. Multiple global updates are included throughout the guideline,...

The...

06/22/2020

Journal of Clinical Pathways

Special Report

Overview of the Updated NCCN Guidelines on Ovarian Cancer

06/17/2020

While ovarian cancer is the second most common gynecologic cancer in the United States, behind uterine cancer,1 it is the top gynecologic cancer in mortality.2 In 2020, an estimated 21,750 new cases of ovarian cancer...

While...

06/17/2020

Journal of Clinical Pathways

News

NCCN Biomarker Guideline Adherence Linked With Decreased Mortality in NSCLC

06/16/2020

Adherence to the National Comprehensive Cancer Network (NCCN) guideline for biomarker testing for non-squamous advanced non-small cell lung cancer (NSCLC) is associated with decreased risk of mortality, according to a recent...

Adherence to the National...

06/16/2020

Journal of Clinical Pathways

New NCCN Guidelines Advise More Physician-led Discussions of Sexual Dysfunction

04/07/2016

JCP Editors

Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...

...

04/07/2016

Journal of Clinical Pathways

NCCN CEO Compares Evidence Blocks With Other Tools to Assess Value of Cancer Care Treatments

04/01/2016

JCP Editors

In a session at their 21st Annual Meeting in Hollywood, FL, National Comprehensive Cancer Network (NCCN) CEO Robert W Carlson, MD, discussed how NCCN Evidence Blocks stack up against other tools currently available...

In a...

04/01/2016

Journal of Clinical Pathways

Adolescent Hodgkin Lymphoma Patients Not Receiving Optimal Follow-up Care

01/18/2016

JCP Editors

Adolescent and young adult (AYAs) survivors of Hodgkin lymphoma may not be receiving the recommended post-treatment care, according to a recent study. Cancer is the leading cause of death in AYAs, and Hodgkin...

...

01/18/2016

Journal of Clinical Pathways

Interview

Evidence Blocks to Evaluate the Relative Value of Oncology Treatments

12/14/2015

Many institutions and health care professionals have been aware of the staggering rise of health care costs. An IMS Health report published in May of 2015 confirmed that drug sales in the United States surpassed $100...

Many...

12/14/2015

Journal of Clinical Pathways